Epinephrinesedationrespiratory depressioncardiopulmonary arrestintravenous corticosteroidssevere bronchospasmbronchospasminhaled beta-agonistsopioid overdose
…Epinephrine is a commonly used agent for a variety of indications and clini…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 388 of 2459HIVemtricitabinehepatitis B virushepatitis Blamivudinecabotegravirtenofovir3TCCAB+RPV LArilpivirine+1 more
…RPV LA) is an effective treatment option for people living with HIV. Unlike regimens containing tenofovir with lamivudine (3TC) or …
insulinCOVID-19T1Dtype 1 diabetesZnT8
…, ZnT8 autoantibodies declined (68.0% vs 71.9%, p=0.002), while insulin autoantibodies remained unchanged (p=0.06). Prevalence of IA2, …
Hodgkin’s diseaseneuroblastomadiffuse midline gliomapediatric sarcomasB cell acute lymphoblastic leukemiaGD2 gangliosidebrain tumorsB-ALLsolid cancersT cell lymphoblastic leukemia+1 more
…he GD2 ganglioside, in pediatric sarcomas by targeting Her2, in Hodgkin’s disease by targeting CD30, in T cell lymphoblastic leukemia by targetin…
T1aBarrett’s cancersT1b diseaseT1bBarrett’s neoplasiaendoscopic submucosal dissectionendoscopic mucosal resectionEMRT1b cancersESD
…median lesion size 20 mm). Cancer was present in 271 cases (178 T1a and 93 T1b). Period 2 had a higher cancer burden (52.3% vs 34.9…
statinintracranial aneurysmsNICI
…-assisted coiling.Objective To investigate whether preoperative statin use reduces NICI volume and whether the effect depends on basel…
pantoprazolegastro-oesophageal reflux diseaseerosive oesophagitisintravenous pantoprazoleGORDOptumEO
…natraemia and thrombocytopenia in patients receiving ≥4 days of pantoprazole treatment versus <4 days.Conclusion The real-world incidence of…
tetanuschlorpromazinediazepammetronidazolepyridoxineSão Tomé e Príncipe
…tapering and referred for outpatient physiotherapy, following a tetanus booster.…
Helicobacter pyloriH. pyloriRAC-7Cochrane LibraryPubMedProQuestScopusDual therapyquadruple therapytriple therapy
…with dual, triple and quadruple therapy first-line regimens for Helicobacter pylori eradication.Design A systematic review and network meta-analysi…
lenvatinibRC48Huazhong University of Science and TechnologyTongji Medical CollegeDisitamab vedotinChemotherapyadvanced biliary tract cancer (BTC)human epidermal growth factor receptor 2 (HER2)-positive BTCUnion Hospital
…e enrolled in this study to receive the combination of RC48 and lenvatinib. The primary study endpoint is objective response rate, and the…
99.5%
Risankizumabustekinumabustekinumab-naiveustekinumab-exposedCrohn’s diseaseUK licensing authoritiesCD
…127) of the cohort, of which 12% (n=92) were serious.Conclusion Risankizumab was effective in a large, real-world, medically refractory CD c…
cystic fibrosisCF-specificCFYOGA-CFCFQ-RYogaSouth Yorkshire and Humber Research Ethics CommitteeRECNCT06120465
…ntroduction Yoga is an emerging exercise choice for people with cystic fibrosis (CF), but evidence of its effect in this population is scarce, …